Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Lymphoma, B-Cell 17Lymphoma, Large B-Cell, Diffuse 16Lymphoma, Non-Hodgkin 12Recurrence 11Burkitt Lymphoma 10Multiple Myeloma 7Lymphoma 7Neoplasms 6Leukemia, Myeloid, Acute 6Lymphoma, Mantle-Cell 5Leukemia 5Pancreatic Neoplasms 4Lymphoma, Follicular 4Leukemia, Lymphocytic, Chronic, B-Cell 4Hematologic Neoplasms 4Carcinoma, Hepatocellular 4Neoplasm, Residual 3Nasopharyngeal Carcinoma 3Leukemia, B-Cell 3Glioma 3Colorectal Neoplasms 3Breast Neoplasms 3Stomach Neoplasms 2Simpson-Golabi-Behmel syndrome 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Osteosarcoma 2Melanoma 2Lymphoma, B-Cell, Marginal Zone 2

Interventions

Cisplatin 24Gemcitabine 16Radiotherapy, Intensity-Modulated 14Fluorouracil 7Radiotherapy 5Docetaxel 5pembrolizumab 4Surveys and Questionnaires 4Carboplatin 4Bevacizumab 4toripalimab 3spartalizumab 3camrelizumab 3Induction Chemotherapy 3Endostatins 3Counseling 3Cetuximab 3Acupuncture Therapy 3sintilimab 2nimotuzumab 2endostar protein 2apatinib 2Psychiatric Rehabilitation 2Paclitaxel 2Nivolumab 2Immunohistochemistry 2Drug Therapy 2Chemoradiotherapy 2Celecoxib 2Capecitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Nasopharyngeal Neoplasms × Immunotherapy, Adoptive × Clear all
NCT02980315 2016-12-02

A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application

The Second Hospital of Nanjing Medical University

Phase 1/2 Unknown
20 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡